Blue Owl Capital (NYSE:OWL) PT Raised to $27.00 at UBS Group

Blue Owl Capital (NYSE:OWL) had its price target boosted by UBS Group from $20.00 to $27.00 in a note issued to investors on Tuesday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. UBS Group’s price objective suggests a potential upside of 16.33% from the stock’s current price.

OWL has been the subject of a number of other reports. Oppenheimer increased their target price on Blue Owl Capital from $21.00 to $24.00 and gave the company an “outperform” rating in a research report on Wednesday, October 16th. Wells Fargo & Company upped their target price on shares of Blue Owl Capital from $18.50 to $21.00 and gave the company an “equal weight” rating in a research report on Wednesday, October 9th. Piper Sandler raised their price objective on Blue Owl Capital from $20.00 to $23.00 and gave the company an “overweight” rating in a research note on Wednesday, October 9th. JMP Securities boosted their target price on Blue Owl Capital from $24.00 to $25.00 and gave the company a “market outperform” rating in a research report on Wednesday, October 9th. Finally, Evercore ISI increased their target price on shares of Blue Owl Capital from $21.00 to $22.00 and gave the company an “outperform” rating in a research note on Tuesday, October 8th. Four investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat, Blue Owl Capital currently has a consensus rating of “Moderate Buy” and an average target price of $21.65.

Blue Owl Capital Stock Down 2.3 %

NYSE OWL traded down $0.55 during trading hours on Tuesday, reaching $23.21. The company’s stock had a trading volume of 813,593 shares, compared to its average volume of 5,233,650. Blue Owl Capital has a 1 year low of $12.11 and a 1 year high of $24.17. The company has a market capitalization of $33.16 billion, a price-to-earnings ratio of 193.42, a PEG ratio of 1.29 and a beta of 1.18. The firm’s 50-day moving average price is $18.86 and its 200-day moving average price is $18.43.

Blue Owl Capital (NYSE:OWL) last issued its quarterly earnings data on Thursday, August 1st. The company reported $0.19 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.19. Blue Owl Capital had a return on equity of 19.15% and a net margin of 4.64%. The firm had revenue of $549.85 million during the quarter, compared to analyst estimates of $507.22 million. During the same quarter last year, the business posted $0.16 earnings per share. Equities research analysts anticipate that Blue Owl Capital will post 0.79 EPS for the current fiscal year.

Institutional Investors Weigh In On Blue Owl Capital

Several large investors have recently added to or reduced their stakes in OWL. Transcendent Capital Group LLC bought a new stake in shares of Blue Owl Capital during the first quarter valued at approximately $26,000. ORG Partners LLC bought a new stake in Blue Owl Capital during the 2nd quarter valued at $32,000. ORG Wealth Partners LLC bought a new stake in Blue Owl Capital during the 3rd quarter valued at $32,000. Family Firm Inc. purchased a new stake in shares of Blue Owl Capital in the 2nd quarter worth $40,000. Finally, Rothschild Investment LLC bought a new position in shares of Blue Owl Capital during the 2nd quarter worth $45,000. 35.85% of the stock is owned by hedge funds and other institutional investors.

Blue Owl Capital Company Profile

Blue Owl Capital Inc operates as an asset manager in the United States. The company offers permanent capital base solutions that enables it to offer holistic framework of capital solutions to middle market companies, large alternative asset managers, and corporate real estate owners and tenants. It also provides direct lending products that offer private credit products comprising diversified, technology, first lien, and opportunistic lending to middle-market companies; liquid credit; GP strategic capital products, which offers capital solutions, including GP minority stakes, GP debt financing, and professional sports minority stakes; and real estate products that focuses on acquiring triple net lease real estate by investment grade or creditworthy tenants.